Skip to content

PINEBRIDGE INVESTMENTS, L.P.: GMED position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of PINEBRIDGE INVESTMENTS, L.P. on GMED, newest first. How the timeline and the estimate are built.

PINEBRIDGE INVESTMENTS, L.P. held 5,724 GMED shares at 2025-09-30 per its 13F-HR filed 2025-11-14.

the latest 13F is the newest step

  1. period ended2025-09-30
    13F 5,724 shares
    Change vs previous 13F -2,356 shares

    <0.01% of the 13F portfolio, value $327,813.

    13F-HR 0001193125-25-281818 filed by PINEBRIDGE INVESTMENTS, L.P.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2025-06-30
    13F 8,080 shares
    Change vs previous 13F -1,980 shares

    <0.01% of the 13F portfolio, value $476,882.

    13F-HR 0000950123-25-007775 filed by PINEBRIDGE INVESTMENTS, L.P.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-03-31
    13F 10,060 shares
    Change vs previous 13F -22,343 shares

    0.01% of the 13F portfolio, value $736,392.

    13F-HR 0000950123-25-005086 filed by PINEBRIDGE INVESTMENTS, L.P.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-12-31
    13F 32,403 shares
    Change vs previous 13F +9,695 shares

    0.02% of the 13F portfolio, value $2,680,052.

    13F-HR 0000950123-25-002424 filed by PINEBRIDGE INVESTMENTS, L.P.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-09-30
    13F 22,708 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $1,624,530.

    13F-HR 0000950123-24-011622 filed by PINEBRIDGE INVESTMENTS, L.P.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).